传感器检测低血糖与患者报告低血糖在1型及胰岛素治疗2型糖尿病患者中的关系:Hypo-METRICS研究
Hypo-METRICS研究纳入276例1型糖尿病和321例胰岛素治疗2型糖尿病患者,佩戴盲法持续葡萄糖监测(CGM)并通过应用记录患者报告低血糖(PRH)10周。结果显示1型糖尿病低血糖发生率显著高于2型糖尿病;65%的传感器检测低血糖(SDH)<70 mg/dL无PRH关联,43%的PRH无SDH关联。结论认为至少一半CGM低血糖无症状,即使低于54 mg/dL,且许多有症状低血糖发生在70 mg/dL以上,两者在临床和研究中不能互换使用,均需记录和处理。
要点
- 1型糖尿病SDH<70 mg/dL中位6.5次/周,2型糖尿病2.1次/周;SDH<54 mg/dL分别为1.2 vs 0.2次/周。
- 65%的SDH<70 mg/dL无PRH关联,43%的PRH无SDH关联。
- 1型糖尿病中SDH<70 mg/dL与PRH关联比例高于2型糖尿病(40% vs 22%),SDH<54 mg/dL为47% vs 25%。
核心结论
- 至少一半CGM检测的低血糖无症状,即使低于54 mg/dL;许多报告的有症状低血糖发生在70 mg/dL以上。
- 在临床和研究环境中,SDH与PRH不能互换使用,两者均需记录和处理。
研究设计与样本
- Hypo-METRICS研究纳入276例1型糖尿病和321例胰岛素治疗2型糖尿病且有低血糖经历者,佩戴盲法CGM并通过Hypo-METRICS应用记录PRH共10周。
主要发现
- 1型糖尿病SDH<70 mg/dL中位6.5次/周(IQR 3.8-10.4)vs 2型糖尿病2.1次/周(IQR 0.8-4.0),1型糖尿病显著更高。
- 1型糖尿病SDH<54 mg/dL中位1.2次/周(IQR 0.4-2.5)vs 2型糖尿病0.2次/周(IQR 0.0-0.5),1型糖尿病显著更高。
- 1型糖尿病PRH中位3.9次/周(IQR 2.4-5.9)vs 2型糖尿病1.1次/周(IQR 0.5-2.0),1型糖尿病显著更高。
- 65%的SDH<70 mg/dL无PRH关联,43%的PRH无SDH关联。
- 1型糖尿病中SDH<70 mg/dL与PRH关联比例高于2型糖尿病(40% vs 22%),SDH<54 mg/dL为47% vs 25%。
临床怎么用
- 在临床和研究环境中,SDH与PRH不能互换使用,两者均需记录和处理。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Use of continuous glucose monitoring (CGM) has led to greater detection of hypoglycemia; the clinical significance of this is not fully understood. The Hypoglycaemia-Measurement, Thresholds and Impacts (Hypo-METRICS) study was designed to investigate the rates and duration of sensor-detected hypoglycemia (SDH) and their relationship with person-reported hypoglycemia (PRH) in people living with type 1 diabetes (T1D) and insulin-treated type 2 diabetes (T2D) with prior experience of hypoglycemia. RESEARCH DESIGN AND METHODS: We recruited 276 participants with T1D and 321 with T2D who wore a blinded CGM and recorded PRH in the Hypo-METRICS app over 10 weeks. Rates of SDH <70 mg/dL, SDH <54 mg/dL, and PRH were expressed as median episodes per week. Episodes of SDH were matched to episodes of PRH that occurred within 1 h. RESULTS: Median [interquartile range] rates of hypoglycemia were significantly higher in T1D versus T2D; for SDH <70 mg/dL (6.5 [3.8-10.4] vs. 2.1 [0.8-4.0]), SDH <54 mg/dL (1.2 [0.4-2.5] vs. 0.2 [0.0-0.5]), and PRH (3.9 [2.4-5.9] vs. 1.1 [0.5-2.0]). Overall, 65% of SDH <70 mg/dL was not associated with PRH, and 43% of PRH had no associated SDH. The median proportion of SDH associated with PRH in T1D was higher for SDH <70 mg/dL (40% vs. 22%) and SDH <54 mg/dL (47% vs. 25%) than in T2D. CONCLUSIONS: The novel findings are that at least half of CGM hypoglycemia is asymptomatic, even below 54 mg/dL, and many reported symptomatic hypoglycemia episodes happen above 70 mg/dL. In the clinical and research setting, these episodes cannot be used interchangeably, and both need to be recorded and addressed.
引用
- Divilly P, Martine-Edith G, Zaremba N, et al. Relationship Between Sensor-Detected Hypoglycemia and Patient-Reported Hypoglycemia in People With Type 1 and Insulin-Treated Type 2 Diabetes: The Hypo-METRICS Study. Diabetes Care. 2024. PMID: 39207738. doi:10.2337/dc23-2332
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。